Key Takeaways
- Leqvio infusion is an FDA-approved LDL cholesterol treatment designed to significantly lower “bad” cholesterol levels.
- Its twice-yearly dosing schedule provides long-lasting cholesterol reduction with just two maintenance infusions per year.
- Compared to daily pills, Leqvio infusion offers convenience and may improve adherence to treatment plans.
- Lowering LDL cholesterol reduces the risk of cardiovascular events such as heart attack and stroke.
- The Infusion Center at Denver Arthritis Clinic provides expert outpatient infusion therapy for cholesterol management in Lowry and Lone Tree. Talk to your cardiologist or primary care provider about a referral for Leqvio infusion to schedule your appointment today.
What Is Leqvio?
Many patients ask, “What is Leqvio?”
Leqvio® (inclisiran) is a prescription injectable medication used as an LDL cholesterol treatment for adults with atherosclerotic cardiovascular disease (ASCVD) or high LDL cholesterol that remains elevated despite statin therapy.
Unlike traditional cholesterol medications taken daily, Leqvio infusion works differently. It uses small interfering RNA (siRNA) technology to reduce the production of PCSK9, a protein that affects how the body clears LDL cholesterol from the bloodstream.
Leqvio Mechanism of Action
To understand the Leqvio mechanism of action, it helps to know how LDL cholesterol is regulated.
- The liver removes LDL (“bad”) cholesterol from the blood using LDL receptors.
- PCSK9 is a protein that breaks down these receptors.
- When PCSK9 levels are high, fewer LDL receptors are available, leading to higher LDL cholesterol.
Leqvio works by blocking the production of PCSK9 in the liver. This allows more LDL receptors to remain active, helping the body remove more LDL cholesterol from the bloodstream.
For more information on cholesterol and cardiovascular risk, the American Heart Association provides helpful educational resources.
Benefit #1: Long-Lasting Cholesterol Reduction with Biannual Infusions
One of the most significant benefits of Leqvio infusion is its extended dosing schedule.
After an initial dose and a follow-up dose at three months, Leqvio is administered just twice per year.
This means:
- Sustained LDL reduction
- Fewer appointments compared to monthly injections
- No daily pill reminders
Clinical studies show that Leqvio can reduce LDL cholesterol levels by approximately 50% when used alongside statin therapy.
For patients who struggle with consistent LDL control, this long-lasting effect provides reassurance and stability.
Benefit #2: Convenience Compared to Daily Medications
Daily cholesterol medications require strict adherence. Missing doses can reduce effectiveness.
With Leqvio infusion, treatment is administered at scheduled appointments in a clinical setting. Patients do not need to remember daily pills or self-inject at home.
Daily Pills vs. Leqvio Infusion
| Feature | Daily Oral Medication | Leqvio Infusion |
|---|---|---|
| Frequency | Daily | Twice per year (after initial doses) |
| Administration | Self-administered | Given in outpatient infusion setting |
| Adherence Risk | Missed doses possible | Scheduled clinical dosing |
| Convenience | Daily routine required | Minimal long-term maintenance |
For many patients searching “infusion therapy near me” for cholesterol management, the convenience factor is a major reason to consider Leqvio.
Benefit #3: Improved Adherence to Treatment Plans
Medication adherence is a critical factor in cholesterol management. Studies consistently show that many patients discontinue or inconsistently take daily cholesterol medications.
Leqvio infusion addresses this issue by:
- Eliminating daily dosing decisions
- Providing supervised administration
- Creating structured follow-up intervals
At The Infusion Center at Denver Arthritis Clinic, infusion therapy is delivered in a comfortable outpatient environment designed for patient convenience. The center offers coordinated scheduling, insurance assistance, and a welcoming setting.
Learn more about infusion services here. Improved adherence means more consistent LDL control—and better long-term cardiovascular outcomes.
Benefit #4: Reduced Risk of Cardiovascular Events
High LDL cholesterol is a major risk factor for:
- Heart attack
- Stroke
- Peripheral artery disease
Lowering LDL cholesterol significantly reduces the risk of cardiovascular events. According to the Centers for Disease Control and Prevention (CDC), maintaining healthy cholesterol levels is a cornerstone of heart disease prevention.
Because Leqvio helps maintain sustained LDL reduction, it plays an important role in comprehensive cardiovascular risk management.
Patients with:
- Established cardiovascular disease
- High baseline LDL levels
- Genetic cholesterol disorders
may particularly benefit from advanced LDL cholesterol treatment strategies.
Benefit #5: How Leqvio Fits Into a Comprehensive Heart Health Strategy
Leqvio infusion is not a standalone solution. It works best as part of a broader heart health plan that includes:
- Statin therapy (when appropriate)
- Healthy diet
- Regular exercise
- Blood pressure control
- Diabetes management
Cardiologists and primary care physicians evaluate:
- LDL cholesterol levels
- Overall cardiovascular risk
- Family history
- Response to existing medications
When LDL remains elevated despite statins, Leqvio may be recommended as an additional therapy.
The Infusion Center at Denver Arthritis Clinic provides outpatient infusion therapy that complements a physician-directed heart health plan in Denver.
What to Expect from a Leqvio Infusion Appointment
Leqvio is administered as a subcutaneous injection in a supervised clinical setting.
At The Infusion Center at Denver Arthritis Clinic, patients benefit from:
- Professional monitoring
- Comfortable outpatient setting
- Insurance coordination support
- Convenient Lowry and Lone Tree locations
Is Leqvio Right for You?
Leqvio infusion may be appropriate if:
- LDL cholesterol remains high despite statins
- You have cardiovascular disease
- You struggle with daily medication adherence
- Your physician recommends PCSK9 pathway targeting therapy
Always consult your cardiologist or primary care physician to determine whether Leqvio fits your individual risk profile.
Talk to Your Doctor About Leqvio Infusion in Denver
If high LDL cholesterol continues to put your heart health at risk, Leqvio infusion offers long-lasting, convenient cholesterol reduction with just two maintenance doses per year.
The Infusion Center at Denver Arthritis Clinic provides outpatient infusion therapy for cholesterol management in Lowry and Lone Tree.
Ask your cardiologist or primary care provider about a referral for Leqvio infusion, then call (303) 394-2828 to schedule your appointment.
Expert infusion therapy near you is available in Denver.
Frequently Asked Questions
What is Leqvio used for?
Leqvio is used to lower LDL (“bad”) cholesterol in adults with cardiovascular disease or high cholesterol not adequately controlled by statins.
How does the Leqvio mechanism of action work?
Leqvio blocks the production of PCSK9 in the liver, allowing the body to remove more LDL cholesterol from the bloodstream.
How often is Leqvio infusion given?
After the first two doses (initial and at 3 months), Leqvio is administered every 6 months.
Is Leqvio better than daily cholesterol pills?
Leqvio offers long-lasting LDL reduction with twice-yearly dosing, which may improve adherence compared to daily medications. Your physician will determine which option is appropriate.
